1Martinez-Vila E, Sieira PI. Current status and perspectives of neuroprotection in ischemic stroke treatment[J]. Cerebrovasc Dis 2001; 11 Suppl 1:60-70.
2Davalos A, Castillo J, alvarez-Sabin J et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials[J]. Stroke. 2002; 33: 2850-2857.
3Saver JL, Wilterdink J. Choline precursors in acute and subacute human stroke: a meta-analysis [J]. Simposium Ferrer: on the neuroprotection routes. Geneva. May 31 2002.
4Saver JL, Wilterdink J. Choline precursors for acute and subacute ischemic and hemorrhagic stroke (Protocol for a Cochrane Review)[DB/CD]. In: The Cochrane Library, Issue 4, 2002. Oxford:Update Software.
5Secades J J, Frontera G. CDP-choline: pharmacological and clinical review[J]. Methods find Exp Clin Pharmacol. 1995 Oct; 17Suppl B: 1-54.
6The Cochrane Central Register of Controlled Trials[DB/CD]. In:The Cochrane Library, Issue 4, 2002. Oxford: Update Software.
7Clark W, Gunion- Rinker L, Lessov N et al. Citicoline treatment for experimental intracerebral hemorrhage in mice [J]. Stroke 1998;29:2136-2140.
8Canete MTA, Donaldo MS, Butac CAY et al. Role of intravenous citicoline for supratentorial hemorrhage (RICH study). 27th International Stroke Conference 2002, San Antonio, USA. Or The Cochrane Central Register of Controlled Trials[DB/CD]. In: The Cochrane Library, Issue 4, 2002. Oxford: Update Software.
9Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDPcholine) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. (Cochrane Review) [DB/CD]. In: The Cochrane Library, Issue 4, 2000. Oxford: Update Software.
